Efficacy as a continuous outcome · adults with cancer and depression
1 finding from 1 review
Efficacy as a dichotomous outcome · adults with cancer and depression
It is very uncertain whether mirtazapine changes efficacy as a dichotomous outcome compared with tricyclic antidepressants (TCA) (very low certainty).
1 finding from 1 review
Acceptability ‐ total dropouts · adults with cancer and depression
It is very uncertain whether mirtazapine changes dropouts due to any cause (acceptability) compared with tricyclic antidepressants (TCA) (very low certainty).
1 finding from 1 review
FEV1 % predicted: relative change from baseline · adults and children with CF with at least one class I mutation (PTC)
1 finding from 1 review
Visual acuity · participants (> 30 years) with cataract and presbyopia
1 finding from 1 review
Mean uncorrected near visual acuity (LogMAR) (1 year) · participants (> 30 years) with cataract and presbyopia
1 finding from 1 review
Mean uncorrected intermediate visual acuity (LogMAR) (1 year) · participants (> 30 years) with cataract and presbyopia
1 finding from 1 review
Mean logMAR visual acuity at 1‐year · participants (> 30 years) with cataract and presbyopia
1 finding from 1 review
Mean contrast sensitivity (1 year) · participants (> 30 years) with cataract and presbyopia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mean quality of life or visual function (measured using Visual Function Index‐14 tool) (1 year) · participants (> 30 years) with cataract and presbyopia
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Adverse events (1 year) · participants (> 30 years) with cataract and presbyopia
1 finding from 1 review
Neonatal mortality · preterm infants at risk of respiratory distress syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Mortality before hospital discharge · preterm infants at risk of respiratory distress syndrome
It is very uncertain whether surfactant treatment guided by rapid tests for surfactant deficiency changes mortality prior to hospital discharge№ of participants: 562 (3 RCTs) compared with surfactant therapy provided to preterm infants with respiratory… (very low certainty).
1 finding from 1 review
RR 1.25 [0.65, 2.41]
Studies not reported
Very low
Bronchopulmonary dysplasia · preterm infants at risk of respiratory distress syndrome
Surfactant treatment guided by rapid tests for surfactant deficiency showed no clear difference in bronchopulmonary dysplasia№ of participants: 562(3 RCTs) compared with surfactant therapy provided to preterm infants with respiratory… (low certainty).
1 finding from 1 review
RR 0.9 [0.61, 1.32]
Studies not reported
Low
Bronchopulmonary dysplasia or mortality ‐ not reported · preterm infants at risk of respiratory distress syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Surfactant utilization № of participants: 562 (3 RCTs) · preterm infants at risk of respiratory distress syndrome
Surfactant treatment guided by rapid tests for surfactant deficiency showed no clear difference in surfactant utilization № of participants: 562 (3 RCTs) compared with surfactant therapy provided to preterm infants with respiratory… (low certainty).
1 finding from 1 review
RR 0.97 [0.85, 1.11]
Studies not reported
Low
Pneumothorax · preterm infants at risk of respiratory distress syndrome
Surfactant treatment guided by rapid tests for surfactant deficiency showed no clear difference in any pneumothorax№ of participants: 506(2 RCTs) compared with surfactant therapy provided to preterm infants with respiratory… (low certainty).
1 finding from 1 review
RR 0.53 [0.15, 1.92]
Studies not reported
Low
Neurodevelopmental outcomes · preterm infants at risk of respiratory distress syndrome
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Diarrhoea prevalence (Children < 5a) · adults and children
The intervention probably leads to lower diarrhoea prevalence (Children < 5a) (moderate certainty).
1 finding from 1 review
Intervention not reported
Diarrhoea prevalence (All ages) · adults and children
The intervention may leads to lower diarrhoea prevalence (All ages) (low certainty).
1 finding from 1 review